Long-term Patient Self-management of Oral Anticoagulation

Archives of Internal Medicine

Volumn 155, Issue 20, 1995, Pages 2185-2189

  Ansell, Jack E ^a   Patel, Neal ^a   Ostrovsky, Daniel ^a   Nozzolillo, Elaine ^a   Peterson, Ann Marie ^a   Fish, Lynn ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADOLESCENT; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOT LYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOSE CALCULATION; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEART VALVE REPLACEMENT; HOMOCYSTINURIA; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTHROMBIN TIME; SELF MEDICATION; TRANSIENT ISCHEMIC ATTACK; VEIN THROMBOSIS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; CAPILLARIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN; INFANT; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGE; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; SELF ADMINISTRATION; WARFARIN;

EID: 0028846277     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1995.00430200066010     Document Type: Article

References (23)

1. Levine MN, Hirsh J, Landefeld S, Raskob G. Hemorrhagic complications of anticoagulant therapy. Chest. 1992;102(suppl):352S-363S.
2. Landefeld SC, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med. 1993;95:315-328.
3. Van der Meer FJM, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy. Arch Intern Med. 1993;153:1557-1562.
4. Lucas FV, Duncan A, Jay R, et al. A novel whole blood capillary technique for measuring the prothrombin time. Am J Clin Pathol. 1987:88:442-446.
5. Belsey RE, Fischer PM, Baer DM. An evaluation of a whole blood prothrombin analyzer designed for use by individuals without formal laboratory training. J Fam Pract. 1991;33:266-271.
6. Weibert RT, Adler DS. Evaluation of a capillary whole blood prothrombin time measurement system. Clin Pharm. 1989:8:864-867.
7. Yano Y, Kambayashi J, Murata K, et al. Bedside monitoring of warfarin therapy by a whole blood capillary coagulation monitor. Thromb Res. 1992;66:583-590.
8. White RH, McCurdy SA, von Marensdorff H, Woodruff DE, Leftgoff L. Home prothrombin time monitoring after initiation of warfarin therapy. Ann Intern Med. 1989;111:730-737.
9. Anderson D, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med. 1993;153:1441-1447.
10. Jennings I, Luddington RJ, Baglin T. Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation. J Clin Pathol. 1991;44:950-953.
11. McCurdy SA, White RH. Accuracy and precision of a portable anticoagulation monitor in a clinical setting. Arch Intern Med. 1992;152:589-592.
12. Tripodi A, Arbini A, Chantarangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio? Thromb Haemost. 1993; 70:921-924.
13. Ansell J, Holden A, Knapic N. Patient self-management of oral anticoagulation guided by capillary whole blood prothrombin times. Arch Intern Med. 1989; 149:2509-2511.
14. Bernardo A, Halhuber C, Horskotte D. Home prothrombin estimation. In: Butchart EG, Bodnar E, eds. Thrombosis, Embolism and Bleeding. London, England: ICR Publishers: 1992:325-330.
15. Tattersall R, Gale E. Patient self-monitoring of blood glucose and refinements of conventional treatment. Am J Med. 1981;70:177-182.
16. Schiffrin A, Belmonte M. Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin—dependent diabetic patients treated with pump and multiple subcutaneous injections. Diabetes Care. 1982;5:479-484.
17. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329:977-986.
18. Rosendaal FR, Cannegieter SC, van der Meer FJM, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236-239.
19. Gottlieb LK, Salem-Chatz S. Anticoagulation in atrial fibrillation: does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med. 1994; 154:1945-1953.
20. Pattacini C, Manotti C, Pini M, Quintavalla R, Dettori AG. A comparative study on the quality of oral anticoagulant therapy (warfarin vs acenocoumarol). Thromb Haemost. 1994;71:188-191.
21. Schachner A, Deviri E, Shabat S. Patient-regulated anticoagulation. In: Butchart EG, Bodnar E, eds. Thrombosis, Embolism and Bleeding. London, England: ICR Publishers; 1992:318-324.
22. DiMatteo MR. Enhancing patient adherence to medical recommendations. JAMA. 1994;271:79-83.
23. Ansell JE, Hamke AK, Holden A, Knapic N. Cost effectiveness of monitoring warfarin therapy using standard vs capillary prothrombin times. Am J Clin Pathol. 1989;91:587-589.